It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings ...

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

To the outside world and its countless health care customers, the data powerhouse IQVIA has portrayed itself as a bastion of ...

IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into ...

Board Certified in Endocrinology, Diabetes, and Metabolism and Internal Medicine, Dr. Caveney leads IQVIA’s Obesity, ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $227.67, ...

With 88 years of legacy, Chung Mei Pharmaceutical is transforming into a global leader in healthcare innovation, driven by ...

Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

The IQVIA management team will also host a conference ... With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. We recently published a list of the ...